These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Occult hepatitis B virus infection in patients with autoimmune liver diseases. Georgiadou SP; Zachou K; Liaskos C; Gabeta S; Rigopoulou EI; Dalekos GN Liver Int; 2009 Mar; 29(3):434-42. PubMed ID: 18694399 [TBL] [Abstract][Full Text] [Related]
30. Implications of gut microbiota in autoimmune liver diseases. Qian Q; He W; Tang R; Ma X Minerva Gastroenterol (Torino); 2023 Mar; 69(1):95-106. PubMed ID: 33793160 [TBL] [Abstract][Full Text] [Related]
31. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Boberg KM; Aadland E; Jahnsen J; Raknerud N; Stiris M; Bell H Scand J Gastroenterol; 1998 Jan; 33(1):99-103. PubMed ID: 9489916 [TBL] [Abstract][Full Text] [Related]
32. [Autoimmune hepatitis and overlap syndrome: diagnosis]. Berg PA; Klein R Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264 [TBL] [Abstract][Full Text] [Related]
36. Causal effects of gut microbiome on autoimmune liver disease: a two-sample Mendelian randomization study. Fu Y; Li J; Zhu Y; Chen C; Liu J; Gu S; Zheng Y; Li Y BMC Med Genomics; 2023 Oct; 16(1):232. PubMed ID: 37789337 [TBL] [Abstract][Full Text] [Related]
37. Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan. Tanaka A; Mori M; Matsumoto K; Ohira H; Tazuma S; Takikawa H Hepatol Res; 2019 Aug; 49(8):881-889. PubMed ID: 30932290 [TBL] [Abstract][Full Text] [Related]